Poseida Therapeutics
Poseida Therapeutics utilizes best-in-class genome engineering capabilities to develop targeted lifesaving therapeutics.
Launch date
Employees
Market cap
€271m
Enterprise valuation
€131m (Public information from Sep 2024)
Share price
$3.61 PSTX
San Diego California (HQ)
Authorizing premium user...